Latest papers

[Tissue polypeptide antigen (TPA)].

Relationship of physical fitness, hormone replacement therapy, and hemostatic risk factors in postmenopausal women.

Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.

[Clinical value of serum tissue polypeptide specific antigen detection for primary hepatic cancer].

FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder.

The bHLH protein MyoR inhibits the differentiation of early embryonic endoderm.

Clinical utility of cytokeratins as tumor markers.

[Use of tumor markers in patients on chronic hemodialysis]. AD - Second Department of Internal Medicine, Nihon University School of Medicine. FAU - Kuno, Tsutomu AU - Kuno T FAU - Kaizu, Kazo AU - Kaizu K LA - jpn PT - Journal Article PT - Review PL - Japan TA - Nihon Rinsho JT - Nihon rinsho. Japanese journal of clinical medicine JID - 0420546 RN - 0 (Antigens, Neoplasm) RN - 0 (Antigens, Tumor-Associated, Carbohydrate) RN - 0 (Biological Markers) RN - 0 (Carcinoembryonic Antigen) RN - 0 (Keratin-19) RN - 0 (Peptide Fragments) RN - 0 (Peptides) RN - 0 (Protein Precursors) RN - 0 (Recombinant Proteins) RN - 0 (Serpins) RN - 0 (Tissue Polypeptide Antigen) RN - 0 (Tumor Markers, Biological) RN - 0 (alpha-Fetoproteins) RN - 0 (antigen CYFRA21.1) RN - 0 (pro-gastrin-releasing peptide (31-98)) RN - 0 (squamous cell carcinoma-related antigen) RN - 53230-14-1 (acarboxyprothrombin) RN - 68238-35-7 (Keratins) RN - 9001-26-7 (Prothrombin) RN - EC 3.4.21.77 (Prostate-Specific Antigen) RN - EC 4.2.1.11 (Phosphopyruvate Hydratase) SB - IM RF - 10 MHDA- 2004/09/24 05:00 PST - ppublish SO - Nihon Rinsho. 2004 Jun;62 Suppl 6:391-4.

Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA

Cytoplasmic c-Fos induced by the YXXQ-derived STAT3 signal requires the co-operative MEK/ERK signal for its nuclear translocation.

Effect of opium smoking on concentrations of carcinoembryonic antigen and tissue polypeptide antigen.

[Clinical importance of determination of tumor markers during follow-up in breast carcinoma].

Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia

How to express tumor markers in bronchoalveolar lavage.

Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).

Clinical equivalence of two cytokeratin markers in mon-small cell lung cancer: a study of tissue polypeptide antigen and cytokeratin 19 fragments.

Usefulness of tissue polypeptide antigen in the follow-up of bladder cancer.

[Clinical study of serum tissue polypeptide-specific antigen in breast cancer].

[Tumor markers in epithelial ovarian cancer]

Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease.